POTS treatment without the wait
In the United States, it’s estimated that 1 to 3 million Americans live with postural orthostatic tachycardia syndrome, or POTS, a common form of dysautonomia.
With the recent COVID-19 pandemic, we are seeing a major increase in POTS cases as many with Long COVID meet the diagnostic criteria for POTS or other forms of dysautonomia.
RTHM Direct connects patients to treatment options from home.
Understanding POTS and Dysautonomia
Tachycardia
Fatigue
Orthostatic intolerance
Fainting
Headaches
Lightheadedness
Causes of POTS
While the exact cause remains uncertain, several potential factors contribute to POTS: hereditary factors, underlying health conditions, viral illness or trauma, autoimmune disorders, toxic exposure, chronic fatigue syndrome, demographics (more common in women aged 15 to 50), anemia, and now commonly seen with Long COVID.
Common POTS symptoms
POTS can cause a range of symptoms, including tachycardia, lightheadedness, fatigue, blood pressure fluctuations, nausea, headaches, and cognitive impairments, significantly impacting daily life.
Is there a cure for POTS?
Postural Orthostatic Tachycardia Syndrome (POTS) is a chronic (lifelong) illness that’s often challenging to diagnose due to its diverse and fluctuating symptoms. Although it typically isn’t life-threatening, POTS significantly impacts daily living and tasks. Fortunately, with proper management, individuals with POTS can experience improvements over time.
Explore our range of POTS treatments
RTHM Direct connects you to the latest treatments for managing POTS.
Pyridostigmine
Pyridostigmine improves autonomic function, particularly in patients experiencing dysautonomia. It enhances communication between nerves and muscles, helping alleviate symptoms like dizziness, fatigue, and exercise intolerance.
Propranolol
A beta-blocker that helps manage symptoms related to dysautonomia, such as elevated heart rate and anxiety. By reducing heart rate and controlling blood pressure, propranolol stabilizes the autonomic nervous system.
Ivabradine
Coming soon - Lowers heart rate without affecting blood pressure, making it ideal for patients with autonomic issues like postural orthostatic tachycardia syndrome (POTS). It helps reduce symptoms such as palpitations, fatigue, and exercise intolerance.
Midodrine
Coming soon - Supports blood pressure regulation, particularly in patients experiencing orthostatic hypotension or lightheadedness. By constricting blood vessels and increasing blood pressure, midodrine reduces dizziness and improves daily functioning.
Explore our range of POTS treatments
RTHM Direct connects you to the latest treatments for managing POTS.
Pyridostigmine
Pyridostigmine improves autonomic function, particularly in patients experiencing dysautonomia. It enhances communication between nerves and muscles, helping alleviate symptoms like dizziness, fatigue, and exercise intolerance.
Propranolol
A beta-blocker that helps manage symptoms related to dysautonomia, such as elevated heart rate and anxiety. By reducing heart rate and controlling blood pressure, propranolol stabilizes the autonomic nervous system.
Ivabradine
Coming soon - Lowers heart rate without affecting blood pressure, making it ideal for patients with autonomic issues like postural orthostatic tachycardia syndrome (POTS). It helps reduce symptoms such as palpitations, fatigue, and exercise intolerance.
Midodrine
Coming soon - Supports blood pressure regulation, particularly in patients experiencing orthostatic hypotension or lightheadedness. By constricting blood vessels and increasing blood pressure, midodrine reduces dizziness and improves daily functioning.
Didn’t find a treatment?
We are continuously vetting and adding new treatments based on the latest research and treatment profile. Let us know what you are looking for and we will take it into account for future developments.
Have POTS symptoms?
Start here!
Although there are no cures for POTS yet the low-risk and research-backed medications above can help patients reclaim their lives.
If you don’t know where to start, try our treatment discovery tool. Our treatment discovery tool takes in your symptoms and their severity levels and provides a tailored list of medications that may support your journey back to health.
Get personalized suggestions based on your specific symptoms and conditions and save time sifting through countless research papers.
Read the latest about POTS from the RTHM team
RTHM Patient voices
RTHM has given me hope. After struggling with Long COVID for two years, even with the help of a Long COVID clinic, I was still doing all of my own research and trying to keep my doctors advised of the state of the art in treatments.”
— Stuart
And in case you missed anything.
-
Dysautonomia refers to a collection of disorders affecting the autonomic nervous system (the system in the body responsible for automatic function, such as heart rate, temperature regulation, and digestion), with postural orthostatic tachycardia syndrome (POTS) being most often seen in connection with Long COVID and ME/CFS.
-
Postural Orthostatic Tachycardia Syndrome (POTS) is a condition that affects how your body responds to changes in position, particularly when transitioning from lying down to standing up.
-
Common symptoms experienced by those with POTS include dizziness or lightheadedness, fainting, brain fog, exercise intolerance, fatigue, blurry vision, heart palpitations, fast heart rate and headaches.
-
Dysautonomia and POTS can arise from various factors. These include autoimmune neuropathies, diabetes, vitamin deficiencies, medications, viral illnesses, and physical trauma.
-
There are currently no medications FDA-approved for the treatment of POTS. However, there are many medications prescribed off-label to help reduce symptoms and regulate heart rate.
-
Yes! In fact, studies show that as may as 79% or Long COVID patients also meet the diagnostic criteria for POTS.
-
At this time, RTHM Direct requires a diagnosis from a primary clinician or specialist.
-
At this time, RTHM Direct offers three medications (midodrine, ivabradine, and propranolol) that are commonly used to address POTS and its associated symptoms.